PSF Mid-Cap Growth Portfolio ALNY Holdings History
PSF Mid-Cap Growth Portfolio's Alnylam Pharmaceuticals Inc Holding Summary
As of 2025-03-31, PSF Mid-Cap Growth Portfolio held 27,041.00 shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $7.30 Mil. This investment constitutes 1.85% of their stock portfolio, and PSF Mid-Cap Growth Portfolio now holds 0.02% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.
The initial trade took place in 2019Q3. And since then PSF Mid-Cap Growth Portfolio has made 8 purchases of ALNY, at an average price of $158.22, for a total of 39,960.00 shares. In addition, there have been 6 sales at an average price of $146.49 for 12,919.00 shares. Based on historical transaction data and ALNY's current price of $315.75, PSF Mid-Cap Growth Portfolio's estimated gain on his ALNY holdings is $4.11 Mil, reflecting a 64.98% gain to date.
PSF Mid-Cap Growth Portfolio ALNY ($315.75) Holding Chart
PSF Mid-Cap Growth Portfolio ALNY ($315.75) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
